OR WAIT null SECS
January 02, 2014
Former US President Jimmy Carter and Pfizer commemorate the 15th anniversary of the International Trachoma Initiative to end blinding trachoma by the year 2020.
The Bristol-Myers Squibb Foundation is awarding 10 grants to fund programs for veterans and their families.
December 16, 2013
Almost 400 new medicines for infectious diseases, including viral infections, bacterial infections, fungal infections and parasitic infections.
December 09, 2013
GDUFA is off to a good start from a facility inspection perspective, but there are storm clouds on the horizon.
December 04, 2013
Jill E. Sackman, D.V.M., PhD, senior consultant at Numerof & Associates, Inc. discusses the market forces impacting biopharmaceutical manufacturing
Pharmaceutical Technology takes a look at the major deals and moves of 2013.
A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
Global spending on medicines is expected to meet the $1 trillion threshold in 2014 and reach $1.17 trillion by 2017, according to a recent report by the IMS Institute for Healthcare Informatics
Legislators agree on a limited bill affirming FDA authority over compounders while setting up a process for national drug tracking.
For its use of innovative technology for the production of seasonal and pandemic influenza vaccines, the Novartis Holly Springs, North Carolina facility was the Overall Winner of the 2013 Facility of the Year Award issued by the International Society for Pharmaceutical Engineering (ISPE).